Related Experiment Video
Updated: Apr 20, 2026
04:41
Glucose-Stimulated Insulin Secretion via Perfusion through the Mice Vasculature with an Intact Pancreas
Published on: July 25, 2025
1.2K
Propofol and diabetes insipidus.
Joseph Soo1, Jonathan Gray1, Gerard Manecke1
1Department of Anesthesiology, University of California San Diego, San Diego, CA 92103, USA.
Journal of Clinical Anesthesia
|December 3, 2014
Summary
Propofol, a common anesthetic, may trigger acute diabetes insipidus during surgery. This case highlights a potential serious adverse event linked to propofol administration in surgical patients.
Area of Science:
- Anesthesiology
- Endocrinology
- Nephrology
Background:
- Propofol is a widely used intravenous anesthetic agent.
- Diabetes insipidus is a condition characterized by impaired water balance.
Observation:
- A patient developed acute diabetes insipidus during intraoperative anesthesia.
- The event was strongly associated with the administration of propofol.
Findings:
- Intraoperative propofol administration can be a potential trigger for acute diabetes insipidus.
- This association suggests a possible mechanism linking propofol to antidiuretic hormone regulation or renal response.
Implications:
- Clinicians should be aware of this potential adverse effect of propofol.
- Further investigation into the pathophysiology is warranted to understand this association better.
Related Concept Videos
01:29Diabetes Insipidus I: Introduction
8
Definition Diabetes insipidus is a disorder marked by the production of large amounts of dilute urine because of impaired vasopressin production, release, or kidney response. The lack of effective vasopressin action limits water reabsorption in the renal collecting ducts, which leads to excessive urinary water loss and intense thirst.Clinical PresentationIndividuals with diabetes insipidus report persistent thirst and very high urine output. In severe cases, fluid intake can reach up to 20...
8
01:22Diabetes Insipidus II: Pathophysiology
8
Normally, water balance is maintained through three interconnected mechanisms: the hypothalamic thirst center, the synthesis and release of antidiuretic hormone (ADH, or vasopressin), and the kidneys' responsiveness to this hormone. ADH is synthesized in the hypothalamus, released from the posterior pituitary, and acts on the distal nephron, allowing water reabsorption and concentrated urine production.Diabetes Insipidus and Its TypesIn diabetes insipidus (DI), this regulatory system is...
8
01:24Parenteral Anesthetics: Overview
978
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
978
01:26Hypoglycemia
3
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
3
01:06Oral Hypoglycemic Agents: Glinides
1000
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
1000
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
1.0K
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
1.0K